Soa Wealth Advisors, Llc. Eli Lilly & CO Transaction History

Soa Wealth Advisors, Llc.

$517 Million
Q3 2024

A detailed history of Soa Wealth Advisors, Llc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Soa Wealth Advisors, Llc. holds 864 shares of LLY stock, worth $654,514. This represents 0.15% of its overall portfolio holdings.

Number of Shares

864

Previous 864 -0.0%

Holding current value

$654,514

Previous $765,000 -0.0%

% of portfolio

0.15%

Previous 0.15%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$772.14 - $960.02 $15,442 - $19,200	20 Added 2.37%	864 $765,000
Q2 2024 Jul 17, 2024	BUY	$724.87 - $909.04 $10,873 - $13,635	15 Added 1.81%	844 $764,000
Q1 2024 Apr 10, 2024	BUY	$592.2 - $792.28 $40,269 - $53,875	68 Added 8.94%	829 $644,000
Q4 2023 Jan 10, 2024	BUY	$525.19 - $619.13 $18,381 - $21,669	35 Added 4.82%	761 $443,000
Q3 2023 Oct 10, 2023	BUY	$434.7 - $599.3 $139,104 - $191,776	320 Added 78.82%	726 $389,000
Q1 2023 Apr 28, 2023	SELL	$310.63 - $364.82 $99,090 - $116,377	-319 Reduced 44.0%	406 $139,000
Q4 2022 Jan 10, 2023	BUY	$321.55 - $374.67 $36,978 - $43,087	115 Added 18.85%	725 $0
Q2 2022 Jul 13, 2022	SELL	$278.73 - $327.27 $1,951 - $2,290	-7 Reduced 1.13%	610 $197,000
Q1 2022 Apr 07, 2022	BUY	$234.69 - $291.66 $75,100 - $93,331	320 Added 107.74%	617 $176,000
Q4 2021 Jan 13, 2022	SELL	$224.85 - $279.04 $71,952 - $89,292	-320 Reduced 51.86%	297 $82,000
Q3 2021 Oct 12, 2021	BUY	$221.6 - $272.71 $64,264 - $79,085	290 Added 88.69%	617 $142,000
Q2 2021 Jul 14, 2021	BUY	$180.55 - $233.54 $4,333 - $5,604	24 Added 7.92%	327 $75,000
Q1 2021 Apr 26, 2021	SELL	$164.32 - $212.72 $985 - $1,276	-6 Reduced 1.94%	303 $56,000
Q4 2020 Mar 10, 2021	BUY	$130.46 - $172.63 $40,312 - $53,342	309 New	309 $63,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $720B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Soa Wealth Advisors, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Soa Wealth Advisors, Llc. with notifications on news.

Account

Soa Wealth Advisors, Llc. Eli Lilly & CO Transaction History